Skip to main content

Doximity, Inc.

corporate_fare Company Profile

Doximity, Inc.

DOCS·NYSE·Technology·CIK 0001516513

Doximity, Inc. is a physician-first technology company with over 3 million registered members as of March 31, 2026. These members include more than 85% of U.S. physicians, covering all 50 states and every medical specialty. The platform also serves two-thirds of U.S. nurse practitioners and physician assistants, and approximately 90% of graduating U.S. medical students. U.S. physicians are defined as MDs/DOs under age 76, not retired, holding an active medical license, and having a physician status on the National Provider Identifier (NPI) registry, totaling approximately 1 million as of March 31, 2026. Registered members include those U.S. physicians who meet these criteria and have claimed or created a Doximity profile. The company's mission is to enhance physician productivity and patient care by providing AI-powered tools built for medicine. These tools enable collaboration, access to medical news and research, career and on-call schedule management, and virtual patient visits. The Clinical AI Suite supports a physician's daily workflow, from patient communication and documentation to answering clinical questions. The platform's core is the largest medical professional network in the nation. Doximity's business model supports its members while delivering value to customers through Marketing, Hiring, and Workflow Solutions.

Doximity, Inc. (NYSE:DOCS) is a publicly traded company in the Technology sector. Wiseek has independently scored 13 items for DOCS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-07, rated 8/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 6 rated 8 or above. Recent SEC coverage for DOCS spans 10-Q, 10-K, 8-K.

Recent high-impact activity:

  • Doximity CEO Says AI Is Unlocking a Bigger Market Than Expected, Shares Surge 34%
  • Doximity Raises FY Outlook, Guides Q2 Above Consensus; Shares Surge 74%
  • Doximity Q1 profit halves as AI spending surges; $91.6M buyback executed
  • Doximity Q1 Profit Halves to $24.3M as AI Spending Surges; Revenue Up 7%
  • Doximity Reports Mixed FY26 Results, Authorizes New $500M Buyback, Appoints New CFO & President, Settles Lawsuit

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
$644.86M
Net Income
$196.05M
Diluted EPS
$0.98
Op. Cash Flow
$326.46M
Free Cash Flow
$326.46M
Gross Profit
$574.54M
Operating Income
$214.92M
Cash & Equivalents
$219.18M
Debt / Equity
0.00×
Net Margin
30.4%
Shares Outstanding
183.06M sh
Source: 10-K · filed 2026-05-19 · accession 0001516513-26-000025

Short Interest & Short Volume

4.92 days to cover

FINRA reported short interest of 12,382,007 shares in DOCS as of the September 15, 2026 settlement, a 11.8% decrease from the prior period — about 4.9 days to cover at its recent average daily volume. On October 2, 2026, 54.2% of DOCS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)12,382,007 shares as of September 15, 2026
Change vs prior period▼ 11.8%
Days to cover4.92 at avg daily volume of 2,515,151
Daily short volume (FINRA facilities)54.2% of 987,033 shares on October 2, 2026
5-day average short volume50.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with D →
$27.93
52-week range · as of 2026-08-06 $17.15 – $76.51
Market cap
$4.98B
Volume
2.7M (1.0× avg)
3-mo avg 2.8M
Live data · 2026-10-05 02:48 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DOCS - Latest Insights

DOCS
Aug 07, 2026, 1:13 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $29.10
Real-time Price: $27.93 info
Change: -$1.17 (-4%) info
Market Cap: $4.978B info
DOCS
Aug 06, 2026, 5:53 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $36.85
Real-time Price: $27.93 info
Change: -$8.92 (-24%) info
Market Cap: $4.978B info
DOCS
Aug 06, 2026, 4:12 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.77
Real-time Price: $27.93 info
Change: +$6.16 (+28%) info
Market Cap: $4.978B info
DOCS
Aug 06, 2026, 4:01 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $27.71
Real-time Price: $27.93 info
Change: +$0.220 (+0.79%) info
Market Cap: $4.978B info
DOCS
May 19, 2026, 4:08 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $19.26
Real-time Price: $27.93 info
Change: +$8.67 (+45%) info
Market Cap: $4.978B info
DOCS
May 14, 2026, 3:54 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $19.15
Real-time Price: $27.93 info
Change: +$8.78 (+46%) info
Market Cap: $4.978B info
DOCS
May 13, 2026, 4:36 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $18.95
Real-time Price: $27.93 info
Change: +$8.98 (+47%) info
Market Cap: $4.978B info
DOCS
May 13, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.52
Real-time Price: $27.93 info
Change: +$8.42 (+43%) info
Market Cap: $4.978B info
DOCS
May 13, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $23.04
Real-time Price: $27.93 info
Change: +$4.89 (+21%) info
Market Cap: $4.978B info
DOCS
Apr 17, 2026, 4:44 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $24.71
Real-time Price: $27.93 info
Change: +$3.22 (+13%) info
Market Cap: $4.978B info
DOCS
Apr 17, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $24.72
Real-time Price: $27.93 info
Change: +$3.21 (+13%) info
Market Cap: $4.978B info
DOCS
Feb 05, 2026, 4:09 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.96
Real-time Price: $27.93 info
Change: +$3.97 (+17%) info
Market Cap: $4.978B info
DOCS
Feb 05, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.05
Real-time Price: $27.93 info
Change: -$2.12 (-7%) info
Market Cap: $4.978B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets